BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19917142)

  • 21. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
    Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
    Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.
    Scholes KE; Martin-Iverson MT
    Psychol Med; 2010 Oct; 40(10):1635-46. PubMed ID: 20018124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
    Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.
    Smeerdijk M; Keet R; Dekker N; van Raaij B; Krikke M; Koeter M; de Haan L; Barrowclough C; Schippers G; Linszen D
    Psychol Med; 2012 Aug; 42(8):1627-36. PubMed ID: 22152121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cannabinoids and mental health].
    Soyka M
    Schmerz; 2003 Aug; 17(4):268-73. PubMed ID: 12923676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Related, induced and associated psychiatric disorders to cannabis].
    Laqueille X
    Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
    Di Forti M; Morrison PD; Butt A; Murray RM
    Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.
    Jockers-Scherübl MC; Wolf T; Radzei N; Schlattmann P; Rentzsch J; Gómez-Carrillo de Castro A; Kühl KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1054-63. PubMed ID: 17482741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emotional paradox: dissociation between explicit and implicit processing of emotional prosody in schizophrenia.
    Roux P; Christophe A; Passerieux C
    Neuropsychologia; 2010 Oct; 48(12):3642-9. PubMed ID: 20801135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Motivational interventions: psychosis and cannabis].
    Favrod J
    Encephale; 2009 Dec; 35 Suppl 6():S209-13. PubMed ID: 20141773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment.
    Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
    J Subst Abuse Treat; 2007 Mar; 32(2):113-9. PubMed ID: 17306720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.